Skip to content
FY2026 GAA: ₱6.79T
PisoScan
Home
Records
Contract awardsInfrastructure projectsCharts & statistics
Entities
Top contractorsProcuring entitiesRegions, provinces & LGUs
Budget
National budget (GAA)Agency budgetsRegions & LGUsFollow the moneyBudget stagesFY2027 proposed budget
Blockchain demo
OverviewBlocksTransactionsHow it worksVerify the chainAPI & mirror kit
Audits
COA audit opinions (LGUs)
More
About PisoScanData sourcesOpen data & OCDS export

Innovating Nuclear Medicine Research and Services: Development of Emerging PET Radiopharmaceuticals for Early Cancer Staging and Assessment of Biologic Functions in Cancer Cells

Department of Science and Technology (DOST) · GAA program line
Program ID:
a040507c009e4d45
Agency code:
19-015
FY2026 appropriation:
₱482,773,000.00 · 24 line items
FY2025 appropriation:
₱498,485,000.00
Source key:
19-015|innovating nuclear medicine research and services development of emerging pet radiopharmaceuticals for early cancer staging and assessment of biologic functions in cancer cells

Appropriation per year

₱0₱250M₱500M₱750M₱1BFY2020: ₱60,000,000.00 (1 line items)2020FY2021: ₱8,546,000.00 (1 line items)2021FY2022: ₱58,546,000.00 (1 line items)2022FY2023: ₱50,000,000.00 (1 line items)2023FY2024: ₱689,387,000.00 (12 line items)2024FY2025: ₱498,485,000.00 (12 line items)2025FY2026: ₱482,773,000.00 (24 line items)2026

Source: Philippine Budget Data API (BetterGov.ph), https://budget.bettergov.ph/api/v1 (CC BY 4.0), snapshot Nov 10, 2026. A program line is an authority to spend, not proof of spending. ₱482.8M in FY2026.